Copyright
©The Author(s) 2021.
World J Hepatol. May 27, 2021; 13(5): 584-594
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.584
Published online May 27, 2021. doi: 10.4254/wjh.v13.i5.584
Univariate HR (95%CI) | P value | |
Sex (male) | 1.36 (0.30-6.24) | 0.693 |
Age | 1.00 (0.96-1.04) | 0.922 |
Pathology (HAS/UDS) | 0.99 (0.22-4.47) | 0.989 |
Largest tumor size | 1.08 (0.97-1.20) | 0.179 |
Tumor number | 1.28 (0.79-2.07) | 0.311 |
AFP | 0.99 (0.74-1.31) | 0.922 |
CA 19-9 | 1.00 (0.99-1.01) | 0.677 |
Adjuvant therapy | 0.00 (0.03-2779) | 0.002 |
- Citation: Kim SJ, Rhu J, Kim JM, Choi GS, Joh JW. Surgical treatment outcomes of primary hepatic sarcomas: A single-center experience. World J Hepatol 2021; 13(5): 584-594
- URL: https://www.wjgnet.com/1948-5182/full/v13/i5/584.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i5.584